Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest

Nature Genetics

Volumn 19, Issue 1, 1998, Pages 39-46

  Smith, Leslie ^a   Liu, Shu Jing ^a   Goodrich, Lisa ^a   Jacobson, David ^a   Degnin, Catherine ^a   Bentley, Nicole ^b   Carr, Antony ^b   Flaggs, Gail ^c   Keegan, Kathleen ^c   Hoekstra, Merl ^c   Thayer, Mathew J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN P53; PROTEIN TYROSINE KINASE; RNA;

ANEUPLOIDY; ANIMAL CELL; ARTICLE; ATAXIA TELANGIECTASIA; CELL CYCLE; CELL DIVISION; CENTROSOME; CHROMOSOME 3Q; DNA DAMAGE; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GAMMA IRRADIATION; GENE; ISOCHROMOSOME; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RHABDOMYOSARCOMA;

ANEUPLOIDY; CELL CYCLE PROTEINS; CELL DIVISION; CHROMOSOMES, HUMAN, PAIR 3; G1 PHASE; HUMANS; ISOCHROMOSOMES; MULTIGENE FAMILY; MUSCLES; MYOD PROTEIN; PROTEIN-SERINE-THREONINE KINASES; RHABDOMYOSARCOMA; TUMOR CELLS, CULTURED;

EID: 0006493706     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0598-39     Document Type: Article

References (51)

1. Dias, P., Parham, D.M., Shapiro, D.N., Webber, B.L. & Houghton, P.J. Myogenic regulatory protein (MyoD1) expression in childhood solid tumours: diagnostic utility in rhabdomyosarcoma. Am. J. Pathol. 137, 1283-1291 (1990).
2. Scrable, H.J., Johnson, D.K., Rinchik, E.M. & Cavenee, W.K. Rhabdomyosarcoma-associated locus and MYOD1 are syntenic but separate loci on the short arm of human chromosome 11. Proc. Natl. Acad. Sci. USA 87, 2182-2186 (1990).
3. Weintraub, H. et al. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. USA 66, 5434-5438 (1989).
4. Tapscott, S.J., Thayer, M.J. & Weintraub, H. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 259, 1450-1453 (1993).
5. Barr, F.G. et al. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nature Genet. 3, 113-117 (1993).
6. Mitchell, C.D., Ventris, J.A., Warr, T.J. & Cowell, J.K. Molecular definition in a somatic cell hybrid of a specific 2:13 translocation breakpoint in childhood rhabdomyosarcoma. Oncogene 6, 89-92 (1991).
7. Shapiro, D.N., Sublett, J.E., Li, B., Downing, J.R. & Naeve, C.W. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 53, 5108-5112 (1993).
8. Davis, R.J., D'Cruz, CM., Lovell, M.A., Biegel, J.A. & Barr, F.G. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 54, 2869-2872 (1994).
9. Bentley, N.J. et al. The Schizosaccharomyces pombe rad3 checkpoint gene. EMBO J. 15, 6641-6651 (1996).
10. Sanchez, Y. et al. Regulation of RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle checkpoint pathways. Science 271, 357-360 (1996).
11. Hari, K.L. et al. The mei-41 gene of D. melanogaster is a structural and functional homolog of the human ataxia telangiectasia gene. Cell 82, 815-821 (1995).
12. Keegan, K.S. et al. The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. Genes Dev 10, 2423-2437 (1996).
13. Cimprich, K.A., Shin, T.B., Keith, C.T. & Schreiber, S.L. cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc. Natl. Acad. Sci. USA 93, 2850-2855 (1996).
14. Fiddler, T.A., Smith, L., Tapscott, S.J. & Thayer, M.J. Amplification of MDM2 inhibits MyoD-mediated myogenesis. Mol. Cell. Biol. 16, 5048-5057 (1996).
15. Fournier, R.E.K. A general high-efficiency procedure for production of microcell hybrids. Proc. Natl. Acad. Sci. USA 78, 6349-6353 (1981).
16. Peterson, C.A., Gordon, H., Hall, Z.W., Paterson, B.M. & Blau, H.M. Negative control of the helix-loop-helix family of myogenic regulators in the NFB mutant. Cell 62, 493-502 (1990).
17. Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S. & Vande-Woude, G.F. Abnormal centrosome amplification in the absence of p53. Science 271, 1744-1747 (1996).
18. Hirano, T., Funahashi, S., Uemura, T. & Yanagida, M. Isolation and characterization of Schizosaccharomyces pombe cut mutants that block nuclear division but not cytokinesis. EMBO J. 5, 2973-2979 (1986).
19. Maltzman, W. & Czyzyk, L. UV irradiation stimulates levels of p53 cellular tumour antigen in nontransformed mouse cells. Mol. Cell. Biol. 4, 1689-1694 (1984).
20. Barak, Y., Juven, T., Haffner, R. & Oren, M. mdm2 expression is induced by wild type p53 activity. EMBO J. 12, 461-468 (1993).
21. Wu, X., Bayle, J.H., Olson, D. & Levine, A.J. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7, 1126-1132 (1993).
22. el-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumour suppression. Cell 75, 817-825 (1993).
23. Deng, C., Zhang, P., Harper, J.W., Elledge, S.J. & Leder, P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684 (1995).
24. Donehower, L.A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221 (1992).
25. Olson, E.N. Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154, 261-272 (1992).
26. Lassar, A.B., Skapek, S.X. & Novitch, B. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6, 788-794 (1994).
27. Benezra, R., Davis, R.L., Lockshon, D., Turner, D.L. & Weintraub, H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49-59 (1990).
28. Li, L. et al. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71, 1181-1194 (1992).
29. Hardy, S., Kong, Y. & Konieczny, S.F. Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylation status of a conserved threonine residue within the DNA-binding domain. Mol. Cell. Biol. 13, 5943-5956 (1993).
30. Rao, S.S., Chu, C. & Kohtz, D.S. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14, 5259-5267 (1994).
31. Skapek, S.X., Rhee, J., Spicer, D.B. & Lassar, A.B. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267, 1022-1024 (1995).
32. Hawley, R.S. & Friend, S.H. Strange bedfellows in even stranger places: the role of ATM in meiotic cells, lymphocytes, tumours, and its functional links to p53. Genes Dev. 10, 2383-2388 (1996).
33. Hoekstra, M.F. Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family. Curr. Opin. Genet. Dev. 7, 170-175 (1997).
34. Carr, A.M. Control of cell cycle arrest by the Mec1sc/Rad3sp DNA structure checkpoint pathway. Curr. Opin. Genet. Dev. 7, 93-98 (1997).
35. Bishop, J.M. The molecular genetics of cancer. Science 235, 305-311 (1987).
36. Elledge, S.J. Cell cycle checkpoints: preventing an identity crisis. Science 274, 1664-1672 (1996).
37. Forozan, F., Karhu, R., Kononen, J., Kallioniemi, A. & Kallioniemi, O.P. Genome screening by comparative genomic hybridization. Trends Genet. 13, 405-409 (1997).
38. Weber-Hall, S. et al. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analysed by comparative genomic hybridization. Cancer Res. 56, 3220-3224 (1996).
39. Speicher, M.R. et al. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res. 55, 1010-1013 (1995).
40. Carey, T.E., Worsham, M.J. & Van-Dyke, D.L. Chromosomal biomarkers in the clonal evolution of head and neck squamous neoplasia. J. Cell. Biochem. Suppl. 213-222 (1993).
41. Jin, Y. et al. Chromosome abnormalities in eighty-three head and neck squamous cell carcinomas: influence of culture conditions on karyotypic pattern. Cancer Res. 53, 2140-2146 (1993).
42. Rao, P.H., Sreekantaiah, C., Schantz, S.P. & Chaganti, R.S. Cytogenetic analysis of 11 squamous cell carcinomas of the head and neck. Cancer Genet. Cytogenet. 77, 60-64 (1994).
43. Ried, T. et al. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res. 54, 1801-1806 (1994).
44. Rabbitts, P., Bergh, J., Douglas, J., Collins, F. & Waters, J. A submicroscopic homozygous deletion at the D3S3 locus in a cell line isolated from a small cell lung carcinoma. Genes Chromosom. Cancer 2, 231-238 (1990).
45. Heselmeyer, K. et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl. Acad. Sci. USA 93, 479-484 (1996).
46. Lengauer, C., Kinzler, K.W. & Vogelstein, B. Genetic instability in colorectal cancers. Nature 386, 623-627 (1997).
47. Lugo, T.G., Handelin, B., Killary, A.M., Housman, D.E. & Fournier, R.E. Isolation of microcell hybrid clones containing retroviral vector insertions into specific human chromosomes. Mol. Cell. Biol. 7, 2814-2820 (1987).
48. Favaloro, J., Freisman, R. & Kamen, R. Transcription maps of polyoma virus-specific RNA: analysis by two dimensional nucleate S1 gel mapping. Methods Enzymol. 65, 718-749 (1980).
49. Rupp, R.A. & Weintraub, H. Ubiquitous MyoD transcription at the midblastula transition precedes induction-dependent MyoD expression in presumptive mesoderm of X. laevis. Cell 65, 927-937 (1991).
50. Yunis, J.J. & Chandler, M.E. High-resolution chromosome analysis in clinical medicine. Prog. Clin. Pathol. 7, 267-288 (1978).
51. Trask, B. & Pinkel, D. Flow cytometry (Academic Press, New York, 1990).